Related Experiment Video

Updated: Jan 13, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

Ligand-receptor pair-based signature score derived from on-treatment tumor specimens predicts immune checkpoint

Huancheng Zeng1, Rendong Zhang1, Qiongzhi Jiang2

  • 1Department of Breast Surgery, Cancer Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China.

Discover Oncology
|January 9, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
BiomarkerImmune checkpoint blockadeLigand-receptor pairsMetastatic melanoma

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.6K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K